| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992024 | Journal of Thoracic Oncology | 2008 | 5 Pages |
Abstract
The prevalence of poor PS is quite high in lung cancer patients. Providers tend to underestimate poor PS. Specific clinical trials and treatment guidelines for this patient population are urgently needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rogerio C. MD, John PhD, Thomas A. MD, Susan PhD, David PhD,